Home › Companies › CYTOKINETICS INC. › 2024-2025

CYTOKINETICS INC. 2024-2025 Proxy Voting Records

Compiled from SEC Form N-PX filings and CYTOKINETICS INC.’s Form 8-K, filed 2025-05-16 (Item 5.07 on EDGAR). Page generated 02 October 2026.

9Reported items
351Asset managers
3,389Fund votes
2025-05-14Meeting date

Proxy season: 2023-2024 2024-2025 2025-2026

Explore CYTOKINETICS INC. in the interactive database Compare manager voting policies

Official 2024-2025 meeting results reported by CYTOKINETICS INC.

These tallies are CYTOKINETICS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2025-05-16 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

CYTOKINETICS INC. — official shareholder meeting results, meeting held 2025-05-14
Ballot item	For	Against	Abstain	Withheld	Broker non-votes	Outcome
Elect Director: John T. Henderson	86,834,097	--	--	14,784,943	8,867,164	Majority: yes
Elect Director: B. Lynne Parshall	98,261,990	--	--	3,357,050	8,867,164	Majority: yes
Elect Director: Muna Bhanji	89,316,977	--	--	12,302,063	8,867,164	Majority: yes
Proposal 2: Approval of the Amendment and Restatement of the Amended and Restated 2004 Equity Incentive Plan to: (i) increase the number of authorized shares reserved for issuance under Amended and Restated 2004 Equity Incentive Plan by 5,000,000 shares of com	97,782,771	3,668,240	168,029	--	8,867,164	Majority: yes
Proposal 3: Approval of an amendment to the Company's Amended and Restated Certificate of Incorporation to increase the number of authorized shares of common stock available for issuance by the Company from 163,000,000 to 326,000,000 shares of common stock	107,322,080	3,009,572	154,552	--	0	Majority: yes
Proposal 4: Ratification of Selection of Ernst & Young LLP as Our Independent Registered Public Accounting Firm for the Fiscal Year Ending December 31, 2025 The stockholders ratified the selection by the Audit Committee of the Board of Directors of Ernst & You	110,254,216	77,441	154,547	--	0	Majority: yes
Proposal 5: Advisory Vote on Executive Compensation The stockholders approved, on an advisory basis, the compensation of the named executive officers, as disclosed in the Company's Proxy Statement for the 2025 Annual Meeting of Shareholders	96,760,272	4,607,831	250,937	--	8,867,164	Majority: yes

Source: CYTOKINETICS INC., Form 8-K, filed with the SEC on 2025-05-16 — read the filing on EDGAR.

How asset managers voted at the CYTOKINETICS INC. 2024-2025 meeting

Each item below shows how the 351 asset managers that disclosed a CYTOKINETICS INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of CYTOKINETICS INC.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.

1. To approve, on an advisory basis, the compensation of Cytokinetics, Incorporated's named executive officers, as disclosed in the Proxy Statement.

SECTION 14A SAY-ON-PAY VOTESMajority of the votes cast: yes

Meeting held 2025-05-14.

Combines 14 wordings of this item as funds reported it.

95% Majority: yes · of votes cast

FOR 95%

FOR: 96,760,272AGAINST: 4,607,831

CYTOKINETICS INC.’s own tally for this item (“Proposal 5: Advisory Vote on Executive Compensation The stockholders approved, on an advisory basis, the compensation of the named executive officers, as disclosed in the Company's Proxy Statement for the 2025 Annual Mee”): 96,760,272 for, 4,607,831 against, per its Form 8-K filed 2025-05-16 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 118,209,139 outstanding shares: 82% for, 4% against (86% of the company cast a for/against vote).

The 347 asset managers below cast 96% of the shares they voted on this item FOR. Fund share totals are not shown for this item: fund-reported shares overlap across filings (an adviser and the funds it manages can each report the same shares), and here their sum exceeds the company's reported shares outstanding.

FOR 96%

FOR: 96.1%AGAINST: 3.7%ABSTAIN: 0.1%UNKNOWN: 0.1%NOT VOTED: 0.0%

Largest asset managers voting on “To approve, on an advisory basis, the compensation of Cytokinetics, Incorporated's named executive officers, a” at CYTOKINETICS INC., 2024-2025
Asset manager	For	Against	Vote
Fidelity	20,067,940	0	For
T. Rowe Price	18,314,757	0	For
Vanguard	16,910,162	846	For
BlackRock	13,323,711	1,007	For
Wellington	7,006,503	0	For
State Street	6,132,177	0	For
GEODE CAPITAL MANAGEMENT, LLC	2,775,839	0	For
Charles Schwab	2,625,311	0	For
Capital Group	2,336,229	0	For
AllianceBernstein	1,829,986	0	For
PICTET ASSET MANAGEMENT SA	1,644,024	0	For
JPMorgan	1,556,538	0	For
ORBIMED ADVISORS LLC	1,509,205	0	For
Vestal Point Capital, LP	1,329,352	0	For
Aberdeen	1,204,842	0	For
RP Management, LLC	980,392	0	For
Northern Trust	942,909	0	For
BROWN ADVISORY INC	917,666	0	For
WESTFIELD CAPITAL MANAGEMENT CO LP	857,530	0	For
Janus Henderson	750,754	0	For
Invesco	0	726,059	Against
Fisher Asset Management, LLC	711,840	0	For
RTW INVESTMENTS, LP	705,635	0	For
MELLON INVESTMENTS Corp	700,931	0	For
Point72	697,969	0	For

Showing the 25 largest of 347 asset managers. See all 347 in the interactive database.

2. TO APPROVE THE AMENDMENT AND RESTATEMENT OF THE CYTOKINETICS AMENDED AND RESTATED 2004 EQUITY INCENTIVE PLAN TO: (I) INCREASE THE NUMBER OF AUTHORIZED SHARES RESERVED FOR ISSUANCE UNDER SUCH PLAN BY 5,000,000 SHARES OF COMMON STOCK AND (II) PROVIDE FOR LIMITATIONS ON THE MAXIMUM GRANT VALUE THAT NON-EXECUTIVE DIRECTORS MAY RECEIVE UNDER SUCH PLAN OF $1,000,000 FOR ANNUAL GRANTS TO CONTINUING DIREC

SHAREHOLDER RIGHTS AND DEFENSESMajority of the votes cast: yes

Meeting held 2025-05-14.

Combines 2 wordings of this item as funds reported it.

96% Majority: yes · of votes cast

FOR 96%

FOR: 97,782,771AGAINST: 3,668,240

CYTOKINETICS INC.’s own tally for this item (“Proposal 2: Approval of the Amendment and Restatement of the Amended and Restated 2004 Equity Incentive Plan to: (i) increase the number of authorized shares reserved for issuance under Amended and Restated 2004 Equity I”): 97,782,771 for, 3,668,240 against, per its Form 8-K filed 2025-05-16 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 118,209,139 outstanding shares: 83% for, 3% against (86% of the company cast a for/against vote).

The 104 asset managers below cast 98% of the shares they voted on this item FOR (58,628,858 for, 922,368 against).

FOR 98%

FOR: 58,628,858 (98.4%)AGAINST: 922,368 (1.5%)ABSTAIN: 34,323 (0.1%)

Largest asset managers voting on “TO APPROVE THE AMENDMENT AND RESTATEMENT OF THE CYTOKINETICS AMENDED AND RESTATED 2004 EQUITY INCENTIVE PLAN T” at CYTOKINETICS INC., 2024-2025
Asset manager	For	Against	Vote
Vanguard	16,589,750	0	For
Fidelity	10,803,423	0	For
BlackRock	8,890,354	0	For
T. Rowe Price	6,814,055	0	For
State Street	1,639,931	103	For
Charles Schwab	1,301,119	0	For
Capital Group	1,168,110	0	For
RP Management, LLC	980,392	0	For
Columbia Threadneedle	663,281	0	For
Jackson National	606,655	0	For
Aberdeen	602,421	0	For
JPMorgan	581,282	0	For
Equitable	556,960	0	For
AllianceBernstein	462,473	0	For
Principal	421,713	0	For
MUTUAL FUND SERIES TRUST	382,079	0	For
HARBOR FUNDS	360,830	0	For
Invesco	315,660	0	For
Prudential/PGIM	4,590	308,154	Against
Goldman Sachs	309,115	0	For
Brown Advisory Funds	294,668	0	For
TIAA	287,327	0	For
American Century	0	283,535	Against
MFS	283,495	0	For
Hartford	271,135	0	For

Showing the 25 largest of 104 asset managers. See all 104 in the interactive database.

3. To elect the three nominees listed below as Class III Directors, each to serve for a three-year term and until their successors are duly elected and qualified: B. Lynne Parshall

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2025-05-14.

Combines 4 wordings of this item as funds reported it.

97% Majority: yes · of votes cast

FOR 97%

FOR: 98,261,990WITHHELD: 3,357,050

CYTOKINETICS INC.’s own tally for this item (“Elect Director: B. Lynne Parshall”): 98,261,990 for, 3,357,050 withheld, per its Form 8-K filed 2025-05-16 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 118,209,139 outstanding shares: 83% for, 3% withheld (86% of the company cast a for/withheld vote).

The 103 asset managers below cast 100% of the shares they voted on this item FOR (58,387,298 for, 0 against).

FOR 98%

FOR: 58,387,298 (98.0%)ABSTAIN: 1,195,206 (2.0%)

Largest asset managers voting on “To elect the three nominees listed below as Class III Directors, each to serve for a three-year term and until” at CYTOKINETICS INC., 2024-2025
Asset manager	For	Abstain	Vote
Vanguard	16,589,750	0	For
Fidelity	10,803,423	0	For
BlackRock	8,890,354	0	For
T. Rowe Price	6,814,055	0	For
State Street	1,639,931	103	For
Charles Schwab	1,301,119	0	For
Capital Group	1,168,110	0	For
RP Management, LLC	980,392	0	For
Columbia Threadneedle	663,281	0	For
Jackson National	606,655	0	For
Aberdeen	602,421	0	For
JPMorgan	581,282	0	For
Equitable	226,839	330,121	Abstain
AllianceBernstein	0	462,473	Abstain
Principal	330,604	91,109	For
MUTUAL FUND SERIES TRUST	382,079	0	For
HARBOR FUNDS	360,830	0	For
Invesco	315,660	0	For
Prudential/PGIM	312,744	0	For
Goldman Sachs	309,115	0	For
Brown Advisory Funds	294,668	0	For
TIAA	287,327	0	For
American Century	283,535	0	For
MFS	283,495	0	For
Hartford	271,135	0	For

Showing the 25 largest of 103 asset managers. See all 103 in the interactive database.

4. To elect the three nominees listed below as Class III Directors, each to serve for a three-year term and until their successors are duly elected and qualified: John T. Henderson

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2025-05-14.

Combines 4 wordings of this item as funds reported it.

85% Majority: yes · of votes cast

FOR 85%WITHHELD 15%

FOR: 86,834,097WITHHELD: 14,784,943

CYTOKINETICS INC.’s own tally for this item (“Elect Director: John T. Henderson”): 86,834,097 for, 14,784,943 withheld, per its Form 8-K filed 2025-05-16 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 118,209,139 outstanding shares: 73% for, 13% withheld (86% of the company cast a for/withheld vote).

The 103 asset managers below cast 100% of the shares they voted on this item FOR (51,208,924 for, 0 against).

FOR 86%ABSTAIN 14%

FOR: 51,208,924 (85.9%)ABSTAIN: 8,373,580 (14.1%)

Largest asset managers voting on “To elect the three nominees listed below as Class III Directors, each to serve for a three-year term and until” at CYTOKINETICS INC., 2024-2025
Asset manager	For	Abstain	Vote
Vanguard	16,588,907	843	For
Fidelity	10,803,423	0	For
BlackRock	8,890,354	0	For
T. Rowe Price	1,481,661	5,332,394	Abstain
State Street	1,639,931	103	For
Charles Schwab	1,301,119	0	For
Capital Group	1,168,110	0	For
RP Management, LLC	980,392	0	For
Columbia Threadneedle	663,281	0	For
Jackson National	225,099	381,556	Abstain
Aberdeen	0	602,421	Abstain
JPMorgan	581,282	0	For
Equitable	226,839	330,121	Abstain
AllianceBernstein	0	462,473	Abstain
Principal	330,604	91,109	For
MUTUAL FUND SERIES TRUST	382,079	0	For
HARBOR FUNDS	360,830	0	For
Invesco	0	315,660	Abstain
Prudential/PGIM	312,744	0	For
Goldman Sachs	309,115	0	For
Brown Advisory Funds	294,668	0	For
TIAA	287,327	0	For
American Century	283,535	0	For
MFS	283,495	0	For
Hartford	271,135	0	For

Showing the 25 largest of 103 asset managers. See all 103 in the interactive database.

5. To elect the three nominees listed below as Class III Directors, each to serve for a three-year term and until their successors are duly elected and qualified: Muna Bhanji

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2025-05-14.

Combines 4 wordings of this item as funds reported it.

88% Majority: yes · of votes cast

FOR 88%12%

FOR: 89,316,977WITHHELD: 12,302,063

CYTOKINETICS INC.’s own tally for this item (“Elect Director: Muna Bhanji”): 89,316,977 for, 12,302,063 withheld, per its Form 8-K filed 2025-05-16 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 118,209,139 outstanding shares: 76% for, 10% withheld (86% of the company cast a for/withheld vote).

The 103 asset managers below cast 100% of the shares they voted on this item FOR (52,336,209 for, 0 against).

FOR 88%12%

FOR: 52,336,209 (87.8%)ABSTAIN: 7,246,295 (12.2%)

Largest asset managers voting on “To elect the three nominees listed below as Class III Directors, each to serve for a three-year term and until” at CYTOKINETICS INC., 2024-2025
Asset manager	For	Abstain	Vote
Vanguard	16,589,750	0	For
Fidelity	10,803,423	0	For
BlackRock	8,890,354	0	For
T. Rowe Price	1,481,661	5,332,394	Abstain
State Street	1,640,034	0	For
Charles Schwab	1,301,119	0	For
Capital Group	1,168,110	0	For
RP Management, LLC	980,392	0	For
Columbia Threadneedle	663,281	0	For
Jackson National	225,099	381,556	Abstain
Aberdeen	602,421	0	For
JPMorgan	581,282	0	For
Equitable	226,839	330,121	Abstain
AllianceBernstein	0	462,473	Abstain
Principal	330,604	91,109	For
MUTUAL FUND SERIES TRUST	382,079	0	For
HARBOR FUNDS	360,830	0	For
Invesco	315,660	0	For
Prudential/PGIM	312,744	0	For
Goldman Sachs	309,115	0	For
Brown Advisory Funds	294,668	0	For
TIAA	287,327	0	For
American Century	283,535	0	For
MFS	283,495	0	For
Hartford	271,135	0	For

Showing the 25 largest of 103 asset managers. See all 103 in the interactive database.

6. To ratify the appointment by the Audit Committee of the Board of Directors of Ernst & Young LLP as the Cytokinetics, Incorporated's independent registered public accounting firm for the fiscal year ending December 31, 2025.

AUDIT-RELATEDMajority of the votes cast: yes

Meeting held 2025-05-14.

Combines 4 wordings of this item as funds reported it.

99.9% Majority: yes · of votes cast

FOR 99.9%

FOR: 110,254,216AGAINST: 77,441

CYTOKINETICS INC.’s own tally for this item (“Proposal 4: Ratification of Selection of Ernst & Young LLP as Our Independent Registered Public Accounting Firm for the Fiscal Year Ending December 31, 2025 The stockholders ratified the selection by the Audit Committee ”): 110,254,216 for, 77,441 against, per its Form 8-K filed 2025-05-16 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 118,209,139 outstanding shares: 93% for, 0.1% against (93% of the company cast a for/against vote).

The 103 asset managers below cast 99.9% of the shares they voted on this item FOR (59,539,691 for, 8,490 against).

FOR 99.9%

FOR: 59,539,691 (99.9%)AGAINST: 8,490 (0.0%)ABSTAIN: 34,323 (0.1%)

Largest asset managers voting on “To ratify the appointment by the Audit Committee of the Board of Directors of Ernst & Young LLP as the Cytokin” at CYTOKINETICS INC., 2024-2025
Asset manager	For	Vote
Vanguard	16,589,750	For
Fidelity	10,803,423	For
BlackRock	8,890,354	For
T. Rowe Price	6,814,055	For
State Street	1,640,034	For
Charles Schwab	1,301,119	For
Capital Group	1,168,110	For
RP Management, LLC	980,392	For
Columbia Threadneedle	663,281	For
Jackson National	606,655	For
Aberdeen	602,421	For
JPMorgan	581,282	For
Equitable	556,960	For
AllianceBernstein	462,473	For
Principal	421,713	For
MUTUAL FUND SERIES TRUST	382,079	For
HARBOR FUNDS	360,830	For
Invesco	315,660	For
Prudential/PGIM	312,744	For
Goldman Sachs	309,115	For
Brown Advisory Funds	294,668	For
TIAA	287,327	For
American Century	283,535	For
MFS	283,495	For
Hartford	271,135	For

Showing the 25 largest of 103 asset managers. See all 103 in the interactive database.

7. TO APPROVE AN AMENDMENT TO CYTOKINETICS, INCORPORATED'S AMENDED AND RESTATED CERTIFICATE OF INCORPORATION TO INCREASE THE NUMBER OF AUTHORIZED SHARES OF COMMON AVAILABLE FOR ISSUANCE BY CYTOKINETICS, INCORPORATED FROM 163,000,000 TO 326,000,000 SHARES OF COMMON STOCK.

CAPITAL STRUCTUREMajority of the votes cast: yes

Meeting held 2025-05-14.

97% Majority: yes · of votes cast

FOR 97%

FOR: 107,322,080AGAINST: 3,009,572

CYTOKINETICS INC.’s own tally for this item (“Proposal 3: Approval of an amendment to the Company's Amended and Restated Certificate of Incorporation to increase the number of authorized shares of common stock available for issuance by the Company from 163,000,000 t”): 107,322,080 for, 3,009,572 against, per its Form 8-K filed 2025-05-16 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 118,209,139 outstanding shares: 91% for, 3% against (93% of the company cast a for/against vote).

The 99 asset managers below cast 99.9% of the shares they voted on this item FOR (59,400,076 for, 56,996 against).

FOR 99.9%

FOR: 59,400,076 (99.9%)AGAINST: 56,996 (0.1%)ABSTAIN: 0 (0.0%)

Largest asset managers voting on “TO APPROVE AN AMENDMENT TO CYTOKINETICS, INCORPORATED'S AMENDED AND RESTATED CERTIFICATE OF INCORPORATION TO I” at CYTOKINETICS INC., 2024-2025
Asset manager	For	Against	Vote
Vanguard	16,589,750	0	For
Fidelity	10,803,423	0	For
BlackRock	8,890,354	0	For
T. Rowe Price	6,814,055	0	For
State Street	1,639,981	53	For
Charles Schwab	1,301,119	0	For
Capital Group	1,168,110	0	For
RP Management, LLC	980,392	0	For
Columbia Threadneedle	663,281	0	For
Jackson National	606,655	0	For
Aberdeen	602,421	0	For
JPMorgan	581,282	0	For
Equitable	556,960	0	For
AllianceBernstein	462,473	0	For
Principal	421,713	0	For
MUTUAL FUND SERIES TRUST	382,079	0	For
HARBOR FUNDS	360,830	0	For
Invesco	315,660	0	For
Prudential/PGIM	308,154	4,590	For
Goldman Sachs	309,115	0	For
Brown Advisory Funds	294,668	0	For
TIAA	287,327	0	For
American Century	283,535	0	For
MFS	283,495	0	For
Hartford	271,135	0	For

Showing the 25 largest of 99 asset managers. See all 99 in the interactive database.

8. Increase Authorized Common Stock

CAPITAL STRUCTURE

Meeting held 2025-05-14.

100% fund support · no official result

FOR 100%

The 5 asset managers below cast 100% of the shares they voted on this item FOR (125,432 for, 0 against).

FOR: 125,432 (100.0%)

Largest asset managers voting on “Increase Authorized Common Stock” at CYTOKINETICS INC., 2024-2025
Asset manager	For	Vote
Erste Asset Management GmbH	60,450	For
Empower	57,236	For
VALUED ADVISERS TRUST	6,670	For
HC CAPITAL TRUST	1,049	For
UNIFIED SERIES TRUST	27	For

9. To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the Proxy Statement.

SECTION 14A SAY-ON-PAY VOTESMajority of the votes cast: yes

Meeting held 2024-05-15 (outside the 2024-2025 season's 1 July to 30 June window; reported in this season's filings).

97% Majority: yes · of votes cast

FOR 97%

FOR: 85,814,395AGAINST: 2,927,007

CYTOKINETICS INC.’s own tally for this item (“Proposal 4: Advisory Vote on Executive Compensation The stockholders approved, on an advisory basis, the compensation of the named executive officers, as disclosed in the 2024 Proxy Statement”): 85,814,395 for, 2,927,007 against, per its Form 8-K filed 2024-05-17 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 118,209,139 outstanding shares: 73% for, 2% against (75% of the company cast a for/against vote).

The 2 asset managers below cast 100% of the shares they voted on this item FOR (1,873 for, 0 against).

FOR 100%

FOR: 1,873 (100.0%)

Largest asset managers voting on “To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in ” at CYTOKINETICS INC., 2024-2025
Asset manager	For	Against	Abstain	Withheld	Vote
COLDSTREAM CAPITAL MANAGEMENT INC	1,873	0	0	0	For
Echo45 Advisors LLC	0	0	0	0	--

Largest CYTOKINETICS INC. shareholders voting in 2024-2025

Ranked by the number of CYTOKINETICS INC. shares each manager voted on the most widely held ballot item of the 2024-2025 meeting, shown as a share of the 118,209,139 shares outstanding at the time of that meeting.

Top CYTOKINETICS INC. shareholders by shares voted, 2024-2025
#	Asset manager	% of shares outstanding
1	Fidelity	16.98%
2	T. Rowe Price	15.49%
3	Vanguard	14.31%
4	BlackRock	11.27%
5	Wellington	5.93%
6	State Street	5.19%
7	GEODE CAPITAL MANAGEMENT, LLC	2.35%
8	Charles Schwab	2.22%
9	Capital Group	1.98%
10	AllianceBernstein	1.55%

Reported CYTOKINETICS INC. ownership

Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).

CYTOKINETICS INC. beneficial owners on record for the 2024-2025 proxy season
Holder	% outstanding	Disclosure
BlackRock	13.17%	13F
Entities affiliated with BlackRock, Inc.	12.90%	DEF14A
The Vanguard Group	10.08%	DEF14A
Entities affiliated with Fidelity Investments	9.43%	DEF14A
FMR (Fidelity)	8.73%	13F
Wellington Management	6.76%	13F
Entities affiliated with Wellington Management Group LLP	5.52%	DEF14A
State Street	5.15%	13F
T. Rowe Price	1.69%	13F
Point72	1.46%	13F

Percentages above are of 118,209,139 shares outstanding, as reported by CYTOKINETICS INC. on its Form 10-K dated 2024-12-31 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from CYTOKINETICS INC.’s 10-K dated 2024-12-31. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.

At CYTOKINETICS INC.'s shareholder meeting held 2025-05-14, in the 2024-2025 proxy season, 351 asset managers reported how they voted in their SEC Form N-PX filings, covering 3,389 separate fund positions. Their filings are grouped here into 9 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — To approve, on an advisory basis, the compensation of Cytokinetics, Incorporated's named… — FOR was 95% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: CYTOKINETICS INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on 2025-05-16.

CYTOKINETICS INC. proxy season coverage: 2023-2024 · 2024-2025 (this page) · 2025-2026.